S‐1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas
Crossref DOI link: https://doi.org/10.1007/s00268-014-2703-z
Published Online: 2014-08-08
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okabayashi, Takehiro
Shima, Yasuo
Iwata, Jun
Morita, Sojiro
Sumiyoshi, Tatsuaki
Kozuki, Akihito
Tokumaru, Teppei
Iiyama, Tatsuo
Kosaki, Takuhiro
Kobayashi, Michiya
Hanazaki, Kazuhiro
Version of Record valid from 2014-08-08
Text and Data Mining valid from 2014-08-08